Cruise vessel ‘Insignia’ calls at New Mangaluru Port

Mangaluru, Jun 10: A youth, who staged suicide drama at Netravati River Bridge near Thokkottu on the outskirts of the city, reportedly found alive in Shivamogga today.

Praveen Saphalya a 28-year-old man from Kurnad village in Bantwal taluk was missing since yesterday. His motorbike was found abandoned on the Netravati bridge at around 7:30 p.m. on Tuesday (June 9).

It was suspected that he had committed suicide by jumping off the bridge. Hence, police and fire fighters had launched a search operation for his body in the river with the help of divers on Wednesday morning.

Meanwhile, the missing person reportedly surfaced in Shivamogga this morning.

According to sources, Saphalya was working as salesman for SLRK Limited, is reportedly deep in debt. Unable to face the harassment of his creditors, he had parked the bike on the bridge and left the city, sources said. Local police are probing the matter.

Also Read: Mangaluru: 33-year-old man found dead on Netravati river bank

Bengaluru, Jun 27: Karnataka witnessed the biggest single-day spike in Covid cases on Saturday as 918 cases were recorded and 11 more deaths were linked to the pandemic. 

In Bengaluru alone, 596 more people tested positive for the infection in the last 24 hours as three more fatalities were also confirmed by the Department of Health and Family Welfare Services.

Following is the district wise tally:

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.